Acute septic cardiomyopathy;Die akute septische Kardiomyopathie

Intensivmedizin und Notfallmedizin

Volumn 34, Issue 5, 1997, Pages 333-351

  Muller Werdan U ^a   Kuhn, C ^a   Heinroth, K ^a   Prondzinsky, R ^a   Loppnow, H ^a   Schumann, H ^a   Darmer, D ^a   Holtz, J ^a   Werdan, K ^a  

^a MARTIN LUTHER UNIVERSITY HALLE WITTENBERG   (Germany)

Author keywords

Cardiomyopathy; NO (nitric oxide); Sepsis; SIRS (systemic inflammatory response syndrome); TNF (tumor necrosis factor )

Indexed keywords

EID: 2542622075     PISSN: 01753851     EISSN: None     Source Type: Journal    
DOI: 10.1007/s003900050060     Document Type: Article

References (57)

1. Schuster H-P (1996) Intensivtherapie bei Sepsis und Multiorganversagen. Springer, Berlin Heidelberg New York, 2. Auflage
2. Doughty LA, Kaplan SS, Carcillo JA (1996) Inflammatory cytokine and nitric oxide responses in pediatric sepsis and organ failure. Crit Care Med 24:1137-1143
3. Werdan K, Boekstegers P, Müller U, Pfeifer A, Pilz G, Reithmann C, Hallström S, Koidl B, Schuster HP, Schlag G (1991) Akute septische Kardiomyopathie: Bestandteil des Multiorganversagens in der Sepsis? Med Klin 86:526-534
4. Werdan K (1996) Prophylaxe und Therapie der akuten septischen Kardiomyopathie. In: Schuster H-P (Hrsg) Intensivtherapie bei Sepsis und Multiorganversagen. Springer, Berlin Heidelberg New York, S. 200-248
5. Romberg E (1921) Die septische akute Myokarditis In: Romberg E (Hrsg) Lehrbuch der Krankheiten des Herzens und der Blutgefäße. Ferdinand Enke, Stuttgart, 3. Auflage, S. 494
6. Müller-Höcker J, Haerty W (1993) Pathomorphological aspects of the heart in septic patients. In: Schlag G, Redl H (eds) Pathophysiology of shock, sepsis, and organ failure. Springer, Berlin Heidelberg New York, pp 853-858
7. Müller-Werdan U, Reithmann C, Werdan K (1996) Cytokines and the heart: Molecular mechanisms of septic cardiomyopathy. R. G. Landes Company, Georgetown USA/Chapman & Hall, New York USA/Springer Heidelberg
8. Bone R (1996) Sir Isaac Newton, sepsis, SIRS, and CARS. Crit Care Med 24:1125-1128
9. American College of Chest Physicians/Society of Critical Care Medicine Consensus Conference Committee (1992) American College of Chest Physicians/Society of Critical Care Medicine Consensus Conference. Definitions for sepsis and multiple organ failure and guidelines for the use of innovative therapies in sepsis. Crit Care Med 20:864-874
10. Werdan K. Müller-Werdan U (1996) Elucidating molecular mechanisms of septic cardiomyopathy - the cardiomyocyte model. Mol Cell Biochem 163/164:291-303
11. Kumar A, Parrillo JE (1995) Nitric oxide and the heart in sepsis. In: Fink MP, Payen D (eds) Role of nitric oxide in sepsis and ARDS (Update in intensive care and emergency medicine 24). Springer-Verlag, Berlin Heidelberg, pp 73-99
12. Müller-Werdan U, Prondzinsky R, Witthaut R, Stache N, Heinroth K, Kuhn C, Schmidt H, Busch I, Werdan K (1997) Das Herz bei Sepsis und MODS. Wien Klin Wochenschr 109, Suppl 1:3-24
13. Reithmann C, Werdan K (1994) Tumor necrosis factor α decreases mositol phosphate formation and phosphatidylinositol-bisphosphate (PIP2) synthesis in rat cardiomyocytes. Naunyn-Schmiedebergs Arch Pharmacol 349:175-182
14. Yokoyama T, Vaca L, Rosen RD, Durante W, Hazarika P, Mann DL (1993) Cellular basis for the negative inotropic effects of tumor necrosis factor-α in the adult mammalian heart. J Clin Invest 92:2303-2312
15. Schumann RR (1995) Lösliche, membranständige und intrazelluläre LPS-Rezeptoren. In: Vogt S (Hrsg) Update: Clinical Immunology. Vol. 4. Pabst Science Publishers, Lengerich, S 12-38
16. 2+-current in cardiomyocytes. Am J Physiol 260:H869-H876
17. Hallström S, Bernhart E, Müller U, Fürst W, Vogl C, Koidl B, Werdan K, Schlag G (1994) A cardiodepressant factor (CDF) isolated from hemofiltrates of patients in septic and/or cardiogenic shock blocks calcium inward current in cardiomyocytes. Shock 2, Suppl:15
18. Kumar A, Thota V, Dee L, Olson J, Uretz E, Parrillo JE (1996) Tumor necrosis factor α and interleukin 1β are responsible for in vitro myocardial cell depression induced by human septic shock serum. J Exp Med 183:949-958
19. Walev I, Vollmer P, Palmer M. Bhakdi S, Rose-John S (1996) Pore-forming toxins trigger shedding of receptors for interleukin 6 and lipopolysaccharide. Proc Natl Acad Sci USA 93:7882-7887
20. Müller-Werdan U, Schumann H, Fuchs R, Loppnow H, Reithmann C, Koch S, Zimny-Arndt U, Schlegel F, Chang He, Darmer D, Jungblut P, Stadler J, Holtz J, Werdan K (in press) Role of cytokines in septic cardiomyopathy. In: Dhalla NS, Zahradka P, Dixon IMC, Beamish RE (eds) Angiotensin II Receptor Blockade: Physiological and Clinical Implications. Kluwer Academic Publishers
21. Vincent J-L, Gris P, Coffernils M, Leon M, Pinsky M, Reuse C, Kahn RJ (1992) Myocardial depression characterizes the fatal course of septic shock. Surgery 111:660-667
22. Parrillo JE (1989) The cardiovascular pathophysiology of sepsis. Ann Rev Med 40:469-485
23. Neuhof H, Soeparwata R, Neuhof C, Scheld HH (1996) Zur pathophysiologischen Rolle von Zytokinen beim kardiopulmonalen Bypass. Intensivther Transfusionsmed 23, Suppl 4:22-28
24. Prondzinsky R, Müller-Werdan U, Pilz G, Witthaut R, Stabenow I, Werdan K (1997) Systemische Entzündungsreaktion extrakorporaler Therapieverfahren (II): Der cardiopulmonale Bypass. Wien Klin Wochenschr, 109:347-354
25. Pilz G, McGinn P, Boekstegers P, Kääb S, Weidenhöfer S, Werdan K (1994) Pseudomonas sepsis does not cause more severe cardiovascular dysfunction in patients than non-Pseudomonas sepsis. Circ Shock 42:174-182
26. Raper R, Sibbald WJ, Driedger AA, Gerow K (1989) Relative myocardial depression in normotensive sepsis. J Crit Care 4:9-18
27. Hallin GW, Simpson SQ, Corwell RE, James DS, Koster FT, Mertz GJ, Levy H (1996) Cardiopulmonary manifestations of hantavirus pulmonary syndrome. Crit Care Med 24:252-258
28. Niemer M, Nemes C, Lundsgaard-Hansen P, Blauhut B (1992) Datenbuch Intensivmedizin (Datenbuch Anästhesiologie und Intensivmedizin, Bd 2). Fischer, Stuttgart Jena New York
29. Prondzinsky R, Stache N, Witthaut R, Winkler M, Fraunberger P, Walli AK, Seidel D, Werdan K (1997) Multiorganversagen (MOV) mit und ohne Sepsis - Inzidenz supra- und ventrikulärer Arrhythmien. Wien Klin Wochenschr 109, Suppl 1:FV13
30. Winchell RJ, Hoyt DB (1996) Spectral analysis of heart rate variability in the ICU. J Surg Res 63:11-16
31. Godin PJ, Buchman TG (1996) Uncoupling of biological oscillators: A complementary hypothesis concerning the pathogenesis of multiple organ dysfunction syndrome. Crit Care Med 24:1107-1116
32. Godin PJ, Fleisher LA, Eidsath A, Vandivier RW, Preas HL, Banks SM, Buchman TG, Suffredini AF (1996) Experimental human endotoxemia increases cardiac regularity: Results from a prospective, randomized, cross-over trial. Crit Care Med 24:1117-1124
33. Smail N, Descorps Declere A, Duranteau J, Vigue B, Samii K (1996) Left ventricular function after severe trauma. Intensive Care Med 22:439-442
34. Connors AF, Speroff T, Dawson NV, Thomas C, Harrell FE, Wagner D, Desbiens N, Goldman L, Wu AW, Califf RM, Fulkerson WJ, Vidaillet H, Broste S, Bellamy P, Lynn J, Knaus WJ for the SUPPORT Investigators (1996) The effectiveness of right heart catheterization in the initial care of critically ill patients. JAMA 276:889-897
35. Dalen JE, Bone RC (1996) Is it time to pull the pulmonary artery catheter? JAMA 276:916-918
36. Coalition for Critical Care Excellence (1995) Standards of evidence for the safety and effectiveness of critical care monitoring devices and related interventions. Crit Care Med 23:1756-1763
37. Thijs LG (1995) Fluid Therapy in Septic Shock. In: Sibbald WJ, Vincent J-L (eds) Clinical trials for the treatment of Sepsis (Update in Intensive Care and Emergency Medicine 19, Vincent J-L, series editor). Springer, Berlin Heidelberg, S. 167-190
38. Vincent J-L, Moreno R, Takala J, Willatts S, De Mendonca B, Bruining H, Reinhart CK, Suter PM, Thijs LG (1996) The SOFA (Sepsis-related Organ Failure Assessment) score to describe organ dysfunction/failure. Intensive Care Med 22:707-710
39. Marecaux G, Pinsky MR, Dupont E, Kahn RJ, Vincent J-L (1996) Blood lactate levels are better prognostic indicators than TNF and IL-6 levels in patients with septic shock. Intensive Care Med 22:404-408
40. Witthaut R, Werdan K (1996) Ergebnisforschung am Beispiel der Sepsis. Internist 37:1249-1259
41. Sakka SG, Reinhart K (1996) Volumentherapie im septischen Schock. Intensiv- und Notfallbehandlung 21:73-79
42. Fang K, Krahmer RL, Rypins EB, Law WR (1996) Starling resistor effects on pulmonary artery occlusion pressure in endotoxin shock provide inaccuracies in left ventricular compliance assessments. Crit Care Med 24:1618-1625
43. Rudis MI, Basha MA, Zarowitz BJ (1996) Is it time to reposition vasopressors and inotropes in sepsis? Crit Care Med 24:525-537
44. Day NPJ, Phu NH, Bethell DP, Mai NTH, Chau TTH, Hien TT, White NJ (1996) The effects of dopamine and adrenaline infusions on acid-base balance and systemic haemodynamics in severe infection. Lancet 348:219-223
45. Reinhart K, Bloos F, Spies C (1995) Vasoactive drug therapy in sepsis. In: Sibbald WJ, Vincent J-L (eds) Clinical Trials for the Treatment of Sepsis (Update in Intensive Care and Emergency Medicine 19; Vincent J-L, series editor). Springer, Berlin Heidelberg, 207-224
46. Maynard ND, Bihari DJ, Dalton R, Smithies MN, Mason RC (1995) Increasing splanchnic blood flow in the critically ill. Chest 108:1648-1654
47. Brivet FG, Kleinknecht DJ, Loirat P, Landais PJM, the French Study Group on Acute Renal Failure (1996) Acute renal failure in intensive care units - Causes, outcome, and prognostic factors of hospital mortality: A prospective, multicenter study. Crit Care Med 24:192-198
48. Chertow GM, Sayegh MH, Allgren RL, Lazarus JM, for the Auriculin Anaritide Acute Renal Failure Study Group (1996) Is the administration of dopamine associated with adverse or favorable outcomes in acute renal failure? Am J Med 101:49-53
49. Thompson BT, Cockrill BA (994) Renal-dose dopamine: a Siren song? Lancet 344:7-8
50. Papapetropoulos A, Abou-Mohamed G, Marczin N, Murad F, Caldwell RW, Catravas JD (1996) Downregulation of nitrovasodilator-induced cyclic GMP accumulation in cells exposed to endotoxin or interleukin-1β. Br J Pharmacol 118:1359-1366
51. Cheifetz IM, Craig DM, Kern FH, Black DR, Hillman ND, Greeley WJ, Ungerleider RM, Smith PK, Meiones JN (1996) Nitric oxide improves transpulmonary vascular mechanics but does not change intrinsic right ventricular contractility in an acute respiratory distress syndrome model with permissive hypercapnia. Crit Care Med 1996, 24:1554-1561
52. Werdan K (1995) Towards a more causal treatment of septic cardiomyopathy. In: Vincent J-L (ed) Yearbook of Intensive Care and Emergency Medicine 1995. Springer, Berlin Heidelberg New York Tokyo, pp 518-538
53. G-nitro-L-arginine infusion in porcine endotoxin shock. Crit Care Med 23:909-918
54. Hoffmann JN, Hartl W, Deppisch R, Faist E, Jochum M, Inthorn D (1996) Effect of hemofiltration on hemodynamics and systemic concentrations of anaphylatoxins and cytokines in human sepsis. Intensive Care Med 22:1360-1367
55. Schumann RR, Rietschel ET (1995) Endotoxin - structure, recognition, cellular response and septic shock. Antiinfective Drugs and Chemotherapy 13:115-124
56. Werdan K, Reithmann C (1992) Differentialtherapie mit Katecholaminen. In: Schüttler J, Schwilden H, Lauven PM (Hrsg) Klinische Pharmakologie und rationale Arzneimitteltherapie-Symposium, Bonn 1990. G. Thieme Verlas, Stuttgart New York. S 133-143
57. Sibbald WJ, Vincent J-L (1995) Roundtable conference on clinical trials for the treatment of sepsis. Chest 107:522-527